Thomas S Lin

Ohio State University

$2,451,525

Attributed

$2,451,525

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $970.8K · FY2005–08

$1M$750K$500K$250K$0

'05

'06

'07

'08

Funding mix

By agency

NIH$2,451,525 · 6

By mechanism

R21$1,684,051 · 3

K23$659,070 · 1

M01$108,404 · 2

Top collaborators

No co-investigators on record.

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchFlavopiridolNeoplasm /Cancer ChemotherapyClinical Trial Phase IMonoclonal AntibodyFludarabineNeoplastic CellChronic Lymphocytic LeukemiaApoptosisMaximum Tolerated DoseIn VivoIn VitroMalignant Lymphoma, Lymphocytic, Intermediate Differentiation, DiffuseMutationGenetic RiskDrug Screening /EvaluationGrowthClinical Trials, Phase IiClinical TrialsDoseB-LymphocytesCellsIndolentDose-Limiting